Eva Esteban Cardeñosa

Learn More
During the first 6 years of the Program of Genetic Counselling in Cancer of Valencia (eastern Spain), 310 mutations (155 in BRCA1 and 155 in BRCA2) in 1,763 hereditary breast (BC) and ovarian cancer(More)
It is well known that the pathogenic mutations in BRCA1 or BRCA2 genes are detected in 5–10% of total breast (BC) and ovarian cancer (OC) and in 20–30% of BC/OC found in families with strong history(More)
BACKGROUND Mutation screening of BRCA1 and BRCA2 (BRCAs) genes is a time-consuming and costly procedure that demands faster and cheaper alternative methods for routine diagnostics. The present study(More)